不同血液净化方式对尿毒症患者甲状腺相关激素水平的影响

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (40 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the changes of free triiodothyronine(FT3),free thyroxine(FT4),and thyroid stimulating hormone(TSH)in uremic patients undergone hemodialysis(HD)and peritonial dialysis(PD)to explore the influence of two different blood purification methods on thyroid related hormones.Methods From January 2011 to December 2014,108 patients in Department of Nephrology,Weifang Yidu Central Hospital and Weihai Traditional Chinese Medicine Hospital were selected as the subjects,and divided into HD group(59 cases)and PD group(49 cases)according to the patients′and their families′wills.The venous blood samples at the early morning were collected before dialysis and 6 months after dialysis in order to detect the concentrations of serum FT3,FT4,and TSH.Results There was no significant difference in FT3,FT4,and TSH levels between before and after treatment in HD group (P＞0.05).The level of serum FT3in PD group after therapy was significantly higher than that before treatment,the difference was statistically significant(P＜0.01).After therapy,the level of serum FT3in PD group was higher than that in HD group,the difference was statistically significant(P＜0.05).The level of serum FT4in PD group was lower than that before treatment with a statistical difference(P＜0.05).The level of serum FT4in PD group was lower than that in HD group after therapy (P＜0.05).For serum TSH levels between before and after treatment in PD group,no significant difference was displayed(P＞0.05).Conclusion HD has no significant effect on thyroid-related hormone levels in patients with uremia.PD can increase serum FT3,reduce the harm of T3in low level to a certain extent,and also lead to a decrease of FT4.The two different therapeutic methods have no impact on thyroid-pituitary feedback circuit.

Key words： Hemodialysis Peritoneal dialysis Uremia Thyroid hormone

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SUN Ming
	LIU Ye-wei
	SUN Yi-jun
	WU Wen-bin
	YU Shu-jun

Cite this article:

SUN Ming,LIU Ye-wei,SUN Yi-jun, et al. Effect of different blood purification methods on thyroid related hormones in uremic patients[J]. 中国当代医药, 2018, 25(13): 67-69.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I13/67

[1]	王永亮，范泉，李秀娟，等.甲状腺功能正常的病态综合征的研究现状[J].实用临床医药杂志，2011，15（23）：167-169.
[2]	赵珉，郝丽，王笑薇，等.慢性肾衰竭患者甲状腺激素水平的变化及意义[J].安徽医学，2009，30（8）：903-904.
[3]	王营营，邹洪斌，张立.老年慢性肾脏病甲状腺功能低下的研究进展[J].中国老年学杂志，2012，（3）：641-643.
[4]	Dagan A，Cleper R，Krause I，et al.Subclinical non-autoimmu hypothyroidism in children with steroid-resistant nephritic syndrome[J].Nephrol Dial Transplant，2012，27（6）：2171-2175.
[5]	彭爱民，杨林，杨芦蓉，等.45例慢性肾脏病血清甲状腺激素与营养代谢的临床探讨[J].重庆医学，2012，41（13）：1319－1321.
[8]	刘家欣，石咏军.终末期肾脏病透析患者合并低T3综合征研究进展[J].中国血液净化，2017，16（3）：195-198.
[9]	陆凤机.肾病综合征甲状腺激素水平异常临床研究进展[J].内科，2010，5（2）：186-188.
[10]	陈民.慢性肾衰竭患者血清锌-α2-糖蛋白水平变化及与营养不良的关系分析[D].辽宁省：大连医科大学，2011.
[6]	Bianco AC，Kim BW，Deiodinases.Implications of the local control of thyroid hormone action[J].J Clin Invest，2006，116（11）：2571-2579.
[7]	Spector DA，Davis PJ，Helderman JH，et al.Thyroid function and metabolic state in chronic renal failure[J].Ann Intern Med，1976，85（6）：724-730.
[11]	陈建强，吴唐英.血液透析与腹膜透析对尿毒症患者超敏C-反应蛋白与甲状腺功能的影响[J].中国当代医药，2015，22（24）：30-32.
[12]	杨小春.肾病患者血清中T3、T4的测定及结果分析[J].齐齐哈尔医学院学报，2001，22（10）：1130.
[13]	杨丽莉，赵宁，谢祥成，等.慢性肾病患者中低T3综合征的发生率及临床意义[J].中国中西医结合肾病杂志，2013，14（3）：242-244.
[14]	王慧敏，崔丽娟，魏玮，等.慢性肾脏病患者血清甲状腺激素测定的临床意义[J].江苏医药，2011，37（14）：1652-1654.
[15]	胡延毅，龙红英，王鲸竹.血液透析患者甲状腺功能异常分析[J].中国老年学杂志，2015，1（35）：247-248.